2-(4-Methoxyphenyl)-4(5)-phenylimidazole

ID: ALA466587

Chembl Id: CHEMBL466587

PubChem CID: 18673182

Max Phase: Preclinical

Molecular Formula: C16H14N2O

Molecular Weight: 250.30

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(-c2nc(-c3ccccc3)c[nH]2)cc1

Standard InChI:  InChI=1S/C16H14N2O/c1-19-14-9-7-13(8-10-14)16-17-11-15(18-16)12-5-3-2-4-6-12/h2-11H,1H3,(H,17,18)

Standard InChI Key:  BUWHNKZFUTUGJW-UHFFFAOYSA-N

Alternative Forms

Associated Targets(Human)

SCN2A Tclin Sodium channel protein type II alpha subunit (504 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Scn8a Sodium channel protein type VIII alpha subunit (53 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mycobacterium tuberculosis (203094 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 250.30Molecular Weight (Monoisotopic): 250.1106AlogP: 3.75#Rotatable Bonds: 3
Polar Surface Area: 37.91Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 13.08CX Basic pKa: 5.35CX LogP: 3.75CX LogD: 3.75
Aromatic Rings: 3Heavy Atoms: 19QED Weighted: 0.77Np Likeness Score: -0.72

References

1. Fantini M, Rivara M, Zuliani V, Kalmar CL, Vacondio F, Silva C, Baheti AR, Singh N, Merrick EC, Katari RS, Cocconcelli G, Ghiron C, Patel MK..  (2009)  2,4(5)-diarylimidazoles as inhibitors of hNaV1.2 sodium channels: pharmacological evaluation and structure-property relationships.,  17  (10): [PMID:19394229] [10.1016/j.bmc.2009.03.067]
2. Zuliani V, Fantini M, Nigam A, Stables JP, Patel MK, Rivara M..  (2010)  Anticonvulsant activity of 2,4(1H)-diarylimidazoles in mice and rats acute seizure models.,  18  (22): [PMID:20943396] [10.1016/j.bmc.2010.09.029]
3. Rivara M, Patel MK, Amori L, Zuliani V..  (2012)  Inhibition of NaV1.6 sodium channel currents by a novel series of 1,4-disubstituted-triazole derivatives obtained via copper-catalyzed click chemistry.,  22  (20): [PMID:22981330] [10.1016/j.bmcl.2012.08.067]
4. Rivara M, Zuliani V.  (2012)  In vivo screening of diarylimidazoles as anticonvulsant agents,  21  (11): [10.1007/s00044-011-9869-9]
5. Pieroni M, Wan B, Zuliani V, Franzblau SG, Costantino G, Rivara M..  (2015)  Discovery of antitubercular 2,4-diphenyl-1H-imidazoles from chemical library repositioning and rational design.,  100  [PMID:26071857] [10.1016/j.ejmech.2015.05.048]

Source